Peng Xin - Search Results

Year	Number of Results
2002	7
2003	4
2004	3
2005	7
2006	5
2007	9
2008	10
2009	9
2010	10
2011	12
2012	14
2013	20
2014	25
2015	36
2016	32
2017	25
2018	43
2019	56
2020	52
2021	80
2022	95
2023	105
2024	124
2025	18

1

Tumor-intrinsic SIRPA promotes sensitivity to checkpoint inhibition immunotherapy in melanoma.

Zhou Z, Chen MM, Luo Y, Mojumdar K, Peng X, Chen H, Kumar SV, Akbani R, Lu Y, Liang H. Zhou Z, et al. Among authors: peng x. Cancer Cell. 2022 Nov 14;40(11):1324-1340.e8. doi: 10.1016/j.ccell.2022.10.012. Epub 2022 Nov 3. Cancer Cell. 2022. PMID: 36332624 Free PMC article.

2

Stellettin B Sensitizes Glioblastoma to DNA-Damaging Treatments by Suppressing PI3K-Mediated Homologous Recombination Repair.

Peng X, Zhang S, Wang Y, Zhou Z, Yu Z, Zhong Z, Zhang L, Chen ZS, Claret FX, Elkabets M, Wang F, Sun F, Wang R, Liang H, Lin HW, Kong D. Peng X, et al. Adv Sci (Weinh). 2023 Jan;10(3):e2205529. doi: 10.1002/advs.202205529. Epub 2022 Dec 1. Adv Sci (Weinh). 2023. PMID: 36453577 Free PMC article.

3

GPR162 activates STING dependent DNA damage pathway as a novel tumor suppressor and radiation sensitizer.

Long Y, Guo J, Chen J, Sun J, Wang H, Peng X, Wang Z, Lai W, Liu N, Shu L, Chen L, Shi Y, Xiao D, Liu S, Tao Y. Long Y, et al. Among authors: peng x. Signal Transduct Target Ther. 2023 Feb 1;8(1):48. doi: 10.1038/s41392-022-01224-3. Signal Transduct Target Ther. 2023. PMID: 36725837 Free PMC article.

4

A novel pan-PI3K inhibitor KTC1101 synergizes with anti-PD-1 therapy by targeting tumor suppression and immune activation.

Peng X, Huang X, Lulu TB, Jia W, Zhang S, Cohen L, Huang S, Fan J, Chen X, Liu S, Wang Y, Wang K, Isoyama S, Dan S, Wang F, Zhang Z, Elkabets M, Kong D. Peng X, et al. Mol Cancer. 2024 Mar 14;23(1):54. doi: 10.1186/s12943-024-01978-0. Mol Cancer. 2024. PMID: 38486218 Free PMC article.

5

Bioinformatic validation and machine learning-based exploration of purine metabolism-related gene signatures in the context of immunotherapeutic strategies for nonspecific orbital inflammation.

Wu Z, Fang C, Hu Y, Peng X, Zhang Z, Yao X, Peng Q. Wu Z, et al. Among authors: peng x. Front Immunol. 2024 Mar 28;15:1318316. doi: 10.3389/fimmu.2024.1318316. eCollection 2024. Front Immunol. 2024. PMID: 38605967 Free PMC article.

6

Extracellular Vesicles Containing circMYBL1 Induce CD44 in Adenoid Cystic Carcinoma Cells and Pulmonary Endothelial Cells to Promote Lung Metastasis.

Fu M, Gao Q, Xiao M, Li RF, Sun XY, Li SL, Peng X, Ge XY. Fu M, et al. Among authors: peng x. Cancer Res. 2024 Aug 1;84(15):2484-2500. doi: 10.1158/0008-5472.CAN-23-3508. Cancer Res. 2024. PMID: 38657100

7

Pharmacological inhibition of MYC to mitigate chemoresistance in preclinical models of squamous cell carcinoma.

Liu S, Qin Z, Mao Y, Wang N, Zhang W, Wang Y, Chen Y, Jia L, Peng X. Liu S, et al. Among authors: peng x. Theranostics. 2024 Jan 1;14(2):622-639. doi: 10.7150/thno.88759. eCollection 2024. Theranostics. 2024. PMID: 38169606 Free PMC article.

8

[Clinical strategies to prevent falls].

Sun Q, Zhang Q, Peng X, Chen Y, Sun H. Sun Q, et al. Among authors: peng x. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2021 Feb;35(2):108-111. doi: 10.13201/j.issn.2096-7993.2021.02.004. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2021. PMID: 33540989 Free PMC article. Review. Chinese.

9

Histones Methyltransferase NSD3 Inhibits Lung Adenocarcinoma Glycolysis Through Interacting with PPP1CB to Decrease STAT3 Signaling Pathway.

Zhou Y, Peng X, Fang C, Peng X, Tang J, Wang Z, Long Y, Chen J, Peng Y, Zhang Z, Zhou Y, Tang J, Liao J, Xiao D, Tao Y, Shi Y, Liu S. Zhou Y, et al. Among authors: peng x. Adv Sci (Weinh). 2024 Oct;11(38):e2400381. doi: 10.1002/advs.202400381. Epub 2024 Aug 9. Adv Sci (Weinh). 2024. PMID: 39119928 Free PMC article.

10

Sequential Inhibition of PARP and BET as a Rational Therapeutic Strategy for Glioblastoma.

Peng X, Huang X, Zhang S, Zhang N, Huang S, Wang Y, Zhong Z, Zhu S, Gao H, Yu Z, Yan X, Tao Z, Dai Y, Zhang Z, Chen X, Wang F, Claret FX, Elkabets M, Ji N, Zhong Y, Kong D. Peng X, et al. Adv Sci (Weinh). 2024 Aug;11(30):e2307747. doi: 10.1002/advs.202307747. Epub 2024 Jun 19. Adv Sci (Weinh). 2024. PMID: 38896791 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

697 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

697 results

Results by year